Cannabis companies like Tilray Brands and Canopy Growth could soon face a more mellow path ahead following President Donald Trump's move to help reclassify the drug's status.

Would you pay money to support a scientific experiment involving illegal drugs? A group of British scientists started a crowdfunding campaign to raise the remaining 25,000 pounds (about $37,600) needed to complete the first scientific study ever to image ...

In a more reasonable world, Ayelet Waldman’s new book on LSD would not need to exist. The drug would be legal and regulated, and taking it would be a perfectly routine response to psychological distress. A memoir that chronicled one’s reaction to the ...

Swiss scientists broke a four-decade-long informal ban on LSD research yesterday when they announced the results of a study in which cancer patients received the drug to curb their anxiety about death. The study, which was published in the Journal of ...

As anyone who has been to Shakedown Street knows, the drug cocktail of LSD and MDMA is referred to as “candyflipping.” But for JR Rahn, the founder and co-CEO of psychedelic drug development startup Mind Medicine Inc., the combination, along with ...

President Trump is expected to sign an executive order as soon as this week that would fast-track the reclassification of cannabis. NBC News' Julie Tsirkin stopped by "Here's the Scoop" to talk about what that could mean for medical use.